Non-Clinical Toxicology and safety assessment of a small molecule
J-20 · 7 déc. 2026 TED (UE) Langue : DE
- Acheteur
- Helmholtz-Zentrum für Infektionsforschung GmbH (Braunschweig)
- Lieu
- Allemagne
- Catégorie
- 73100000 — Recherche et développement
- Montant estimé
- Non précisé
- Date limite
- 7 déc. 2026
- Procédure
- open
- Publication
- 27 oct. 2026
Objet du marché
The overall objective of the present project is to conduct a comprehensive nonclinical toxicology and safety assessment program for a small-molecule drug candidate. The program is intended to characterize the toxicological and safety pharmacology profile of the test item following intravenous infusion and to generate the nonclinical safety data required to support a first-in-human clinical trial and subsequent clinical development. The program shall be conducted in accordance with applicable regulatory requirements and guidelines and shall generate data and documentation suitable for regulatory submissions in the European Union and the United States. Particular attention shall be given to the assessment of renal safety, including the characterization of potential effects of both the test item and the vehicle on renal function and renal toxicity. In addition, the program includes the toxicological assessment of the test item following dermal administration to support the potential clinical evaluation of a semisolid formulation for topical administration. The dermal program is behind a Go/No-Go decision.
🤖 Ce marché est-il fait pour vous ?
L’IA d’Adjudy analyse cet avis pour votre entreprise : résumé, exigences, risques, questions à poser et premier jet de mémoire technique.
Analyser ce marché gratuitementSource : TED — Office des publications de l’Union européenne. Informations reproduites à titre informatif ; seul l’avis officiel fait foi.